Skip to main content
Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — Thursday, March 7, 2024

Thursday, March 7, 2024 at 8:00 a.m.
Posted: February 2, 2024 1:18 p.m.

Overview   of Board of Registration in Pharmacy (via Webex) — Thursday, March 7, 2024

A meeting of the Board of Registration in Pharmacy: This meeting is open to the public by Webex or telephone.

Join by Webex

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Access code: 253 018 21885

Agenda

Time      

#

Item

8:00

I

CALL TO ORDER

8:02

II

APPROVAL OF AGENDA

8:05

III

APPROVAL OF BOARD MINUTES

  • Draft of February 1, 2024, Regular Session Minutes

8:10

IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation  
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03

8:30

V

RECONSIDERATIONS

  • CVS Pharmacy #26; DS2912; PHA-2023-0104
  • CVS Pharmacy #23; DS90049; PHA-2022-0108

8:45

VI

REVIEW OF COMPLIANCE

  • Blue Hill Pharmacy, License No. DS89942 - PHA-2022-0122

9:00

VII

APPLICATIONS

  • Blue Hill Pharmacy; DS89942 -  Change Pharmacy Hours of Operation 
  • CVS/Specialty; DS3416 – Renovation
  • BMC Pharmacy at South Boston – New Community Pharmacy
  • BILH Pharmacy 41 Mall Rd, Burlington– New Community Pharmacy
  • Bravo Pharmacy; DS89981 – Relocation
  • Nephron Sterile Compounding Center, LLC - Non-Resident Outsourcing

10:00

VIII

FILE REVIEW

1

CAS-2022-1376

PHA-2022-0207

Nephron SC, Inc, NO00036

2

CAS-2023-0867

PHA-2023-0170

SOFIE, NU00021

3

CAS-2023-1092

PHA-2024-0013

SOFIE, NU00021

4

CASE-2023-0564

PHA-2024-0014

SOFIE, NU00021

5

CASE-2023-0453

INV8186

BWH Nuclear Pharmacy, NU16

6

CASE-2023-0754

INV8849

BWH Nuclear Pharmacy, NU16

7

CASE-2023-0762

PHA-2023-0265

Walgreens #5445, DS2964

8

CAS-2023-0522

PHA-2023-0234

Imad Haidardiab, PH24533

9

CASE-2023-0630

PHA-2023-0236

Walgreens #17531, DS90420

10

CASE-2023-0559

PHA-2023-0216

Walgreens #15390, DS89867

11

CASE-2023-0691

PHA-2023-0249

Tufts Medicine Infusions Services, DS90378

12

CASE-2023-0423

PHA-2023-0177

Fresenius Kabi Compounding, RO00002

13

CAS-2023-1127

PHA-2023-0195

Michael Martin, PH19637

14

CASE-2023-0509

PHA-2023-0232

Walgreens 4966, DS2924

15

CASE-2023-0398

INV8069

Paul R Casale, PT23845

16

CASE-2023-0557

PHA-2023-0198

Market 32, DS2526

17

CASE-2023-0690

INV8698

Paul Rohde, PH15575

18

CASE-2023-0657

PHA-2023-0238

McNabb Pharmacy, DS90087

19

CASE-2023-0408

PHA-2023-0243

Walgreens #7063, DS3238

20

CASE-2023-0440

PHA-2023-0244

Walgreens #17545, DS90127

21

CASE-2023-0625

PHA-2023-0237

Walgreens #5756, DS3252

22

CASE-2023-0688

PHA-2023-0248

New England Life Care, DS90241

23

CASE-2023-0621

PHA-2023-0218

ProCare LTC, DS90042

24

CASE-2023-0485

PHA-2023-0225

CAPS, DS3312

25

CASE-2023-0689

PHA-2023-0247

Partners of MA, DS3419

26

CASE-2023-0587

PHA-2023-0201

Amherst Pharmacy, DS89775

27

CASE-2023-0518

PHA-2023-0233

CVS #1531, DS89663

28

CASE-2023-0685

PHA-2023-0255

CVS #11131, DS99287

29

CASE-2023-0561

PHA-2023-0257

CVS #4200, DS89646

30

CASE-2023-0491

PHA-2023-0208

CVS #17589, DS90006

31

CASE-2023-0516

PHA-2023-0210

CVS #1238, DS2058

32

CASE-2023-0543

PHA-2023-0258

CVS #1002, DS3060

33

CASE-2023-0483

PHA-2023-0226

CVS #1852, DS3462

34

CAS-2023-0819

PHA-2023-0145

Wegman Food Market, Inc, DS89914

35

CAS-2023-0819

INV8500

Matthew Ward, PH234090

36

CASE-2023-0567

PHA-2023-0200

CVS #2201, DS2770

11:30

LUNCH BREAK

12:00

IX

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to review a petition for reinstatement; review a consent agreement for participation in PSUD and to evaluate the Good Moral Character as required for registration for a pending applicant. The

1:00

X

ADJUDICATORY SESSION (M.G.L. ch. 30A, §18)

1:15

XI

M.G.L. c. 112, § 65C SESSION

4:00

XII

ADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback